Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations - PubMed (original) (raw)
Review
doi: 10.1038/nrc2054.
Affiliations
- PMID: 18034184
- DOI: 10.1038/nrc2054
Review
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
James D Fackenthal et al. Nat Rev Cancer. 2007 Dec.
Abstract
Germline mutations in the BRCA1 or BRCA2 tumour-suppressor genes are strong predictors of breast and/or ovarian cancer development. The contribution of these mutations to breast cancer risk within any specific population is a function of both their prevalence and their penetrance. Mutation prevalence varies among ethnic groups and may be influenced by founder mutations. Penetrance can be influenced by mutation-specific phenotypes and the potential modifying effects of the patient's own genetic and environmental background. Although estimates of both mutation prevalence and mutation penetrance rates are inconsistent and occasionally controversial, understanding them is crucial for providing accurate risk information to each patient.
Similar articles
- Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA. Risch HA, et al. J Natl Cancer Inst. 2006 Dec 6;98(23):1694-706. doi: 10.1093/jnci/djj465. J Natl Cancer Inst. 2006. PMID: 17148771 - The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Díez O, Alonso MC, Lazaro C, Blanco I, Sánchez-de-Abajo A, Caldés T, Blanco A, Graña B, Durán M, Velasco E, Chirivella I, Cardeñosa EE, Tejada MI, Beristain E, Miramar MD, Calvo MT, Martínez E, Guillén C, Salazar R, San Román C, Antoniou AC, Urioste M, Benítez J. Milne RL, et al. Clin Cancer Res. 2008 May 1;14(9):2861-9. doi: 10.1158/1078-0432.CCR-07-4436. Clin Cancer Res. 2008. PMID: 18451254 - Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
Bonadona V, Sinilnikova OM, Chopin S, Antoniou AC, Mignotte H, Mathevet P, Brémond A, Martin A, Bobin JY, Romestaing P, Raudrant D, Rudigoz RC, Léoné M, Chauvin F, Easton DF, Lenoir GM, Lasset C. Bonadona V, et al. Genes Chromosomes Cancer. 2005 Aug;43(4):404-13. doi: 10.1002/gcc.20199. Genes Chromosomes Cancer. 2005. PMID: 15887246 - Genomic rearrangements in the BRCA1 and BRCA2 genes.
Mazoyer S. Mazoyer S. Hum Mutat. 2005 May;25(5):415-22. doi: 10.1002/humu.20169. Hum Mutat. 2005. PMID: 15832305 Review. - Pitfalls and caveats in BRCA sequencing.
Bellosillo B, Tusquets I. Bellosillo B, et al. Ultrastruct Pathol. 2006 May-Jun;30(3):229-35. doi: 10.1080/01913120500521281. Ultrastruct Pathol. 2006. PMID: 16825125 Review.
Cited by
- The highest frequency of BRCA1 c.3700_3704del detected among Albanians from Kosovo.
Kostovska IM, Jakovchevska S, Özdemir MJ, Kiprijanovska S, Kubelka-Sabit K, Jasar D, Iljovska M, Lazareva E, Smichkoska S, Plaseska-Karanfilska D. Kostovska IM, et al. Rep Pract Oncol Radiother. 2022 May 19;27(2):303-309. doi: 10.5603/RPOR.a2022.0030. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36299383 Free PMC article. - Triple-negative breast cancers: an updated review on treatment options.
Reddy KB. Reddy KB. Curr Oncol. 2011 Aug;18(4):e173-9. doi: 10.3747/co.v18i4.738. Curr Oncol. 2011. PMID: 21874107 Free PMC article. - BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance.
Gorodetska I, Kozeretska I, Dubrovska A. Gorodetska I, et al. J Cancer. 2019 May 14;10(9):2109-2127. doi: 10.7150/jca.30410. eCollection 2019. J Cancer. 2019. PMID: 31205572 Free PMC article. Review. - Capillary electrophoresis as alternative method to detect tumor genetic mutations: the model built on the founder BRCA1 c.4964_4982del19 variant.
De Bonis M, Minucci A, Scaglione GL, De Paolis E, Zannoni G, Scambia G, Capoluongo E. De Bonis M, et al. Fam Cancer. 2019 Jan;18(1):29-35. doi: 10.1007/s10689-018-0094-2. Fam Cancer. 2019. PMID: 29934687 - RAD51C germline mutations in breast and ovarian cancer cases from high-risk families.
Clague J, Wilhoite G, Adamson A, Bailis A, Weitzel JN, Neuhausen SL. Clague J, et al. PLoS One. 2011;6(9):e25632. doi: 10.1371/journal.pone.0025632. Epub 2011 Sep 28. PLoS One. 2011. PMID: 21980511 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous